EN HU

Nagy Béla

Name: Nagy Béla
Affiliation:
  • Debreceni Egyetem / University of Debrecen
Other profiles: MTMT
Degree:
  • PhD, Debreceni Egyetem (2010)

Publication list

Uploaded publications:
104
Publications in DEA:
104
OA:
58
Date range:
2003-2025
2025
1.
Fejes, Z., Fábián, A., Bartha-Tatár, A., Nagy, B. J., Varga, I.: A parodontitis progresszióját jelző potenciális biomarkerek (GOT, CRP és albumin) értékelése 2-es típusú cukorbetegek nyálmintáiban.
Orv. hetil. 166 (16), 613-622, 2025.
Journal metrics:
Q4 Medicine (miscellaneous) (2024)
2024
2.
Tóth, A., Lente, G., Csiki, D. M., Balogh, E., Szöőr, Á., Nagy, B. J., Jeney, V.: Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification.
Front. Pharmacol. 15, 1-12, (article identifier: 1399248), 2024.
Journal metrics:
Q1 Pharmacology
Q1 Pharmacology (medical)
3.
Sütő, R., Pócsi, M., Fagyas, M., Kalina, E., Fejes, Z., Szentkereszty, Z., Kappelmayer, J., Nagy, B. J.: Comparison of Different Vascular Biomarkers for Predicting In-Hospital Mortality in Severe SARS-CoV-2 Infection.
Microorganisms. 12 (1), 1-15, (article identifier: 229), 2024.
Journal metrics:
Q2 Microbiology
Q2 Microbiology (medical)
Q2 Virology
4.
Váradi, J., Oláh, B., Hosszú, D., Fenyvesi, F., Gálné Remenyik, J., Homoki, J., Nagy, B. J., Fejes, Z., Bácskay, I., Klusóczki, Á.: Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis.
Eur. J. Pharm. Sci. 200, 1-10, (article identifier: 106846), 2024.
Journal metrics:
Q1 Pharmaceutical Science
5.
Tóth, E., Fagyas, M., Nagy, B. J., Mányiné Siket, I., Szőke, B., Mártha, L., Mahdi, M., Erdősi, G., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bácsi, A., Szekanecz, Z., Bai, P., Tóth, A.: Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients.
GeroScience. 46 (2), 1561-1574, 2024.
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
6.
Ababneh, H. M., Tóth, A., Lente, G., Balogh, E., Csiki, D. M., Nagy, B. J., Szöőr, Á., Jeney, V.: High phosphate and calcium induce osteoblastic phenotype switching and calcification of corneal epithelial cells in a Runx2-dependent and synergistic manner; a possible mechanism of chronic kidney disease-associated corneal calcification.
Biochim. Biophys. Acta. Mol. Basis Dis. 1870 (5), 1-20, (article identifier: 167171), 2024.
Journal metrics:
Q1 Molecular Biology
Q1 Molecular Medicine
7.
Kappelmayer, J., Bekéné Debreceni, I., Fejes, Z., Nagy, B. J.: Inflammation, Sepsis, and the Coagulation System.
Hamostaseologie. 44 (4), 268-276, 2024.
Journal metrics:
Q2 Hematology
8.
Krajcsir, B., Pócsi, M., Fejes, Z., Nagy, B. J., Kappelmayer, J., Bekéné Debreceni, I.: Ponatinib Induces a Procoagulant Phenotype in Human Coronary Endothelial Cells via Inducing Apoptosis.
Pharmaceutics. 16 (4), 1-14, (article identifier: 559), 2024.
Journal metrics:
D1 Pharmaceutical Science
9.
Bartha-Tatár, A., Sinkovits, G., Schnur, J., Maráczi, V., Dávid, M., Zsigmond, B., Rimanóczi, É., Szalay, B., Bíró, E., Bekő, G., Varga, P., Szabó, T., Fagyas, M., Fejes, Z., Kappelmayer, J., Nagy, B. J.: Prognostic Value of Baseline Serum Pro-Inflammatory Cytokines in Severe Multisystem Inflammatory Syndrome in Children.
J Clin Med. 13 (23), 1-14, (article identifier: 7177), 2024.
Journal metrics:
Q1 Medicine (miscellaneous)
10.
Banerjee, M., Rowley, J. W., Stubben, C. J., Tolley, N. D., Freson, K., Nelson, B., Nagy, B. J., Fejes, Z., Blair, A. M., Turro, E., Gresele, P., Taranta, G. C., Bury, L., Falcinelli, E., Lordkipanidzé, M., Alessi, M. C., Johnson, A. D., Bakchoul, T., Ramstrom, S., Frontini, M., Camera, M., Brambilla, M., Campbell, R. A., Rondina, M. T.: Prospective, international, multisite comparison of platelet isolation techniques for genome-wide transcriptomics: communication from the SSC of the ISTH.
Journal of Thrombosis and Haemostasis. 22 (10), 2922-2934, 2024.
Journal metrics:
Q1 Hematology
D1 Medicine (miscellaneous)
2023
11.
Bartha-Tatár, A., Kappelmayer, J., Nagy, B. J.: A klasszikus szérumtumormarkerek helye a felnőttkori daganatok kivizsgálásában és a terápia monitorizálásában.
Magy Onkol. 67 (2), 116-123, 2023.
Journal metrics:
Q4 Medicine (miscellaneous)
Q4 Oncology
12.
Stercel, V., Lóczi, L., Kadenczki, O., Nemes, É., Nagy, B. J., Hodossy-Takács, R., Szabó, A. Á., Fagyas, M., Kappelmayer, J., Szabó, T., Bagoly, Z.: Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease.
Front. Immunol. 14, 1-12, (article identifier: 1257072), 2023.
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
13.
Sütő, R., Pócsi, M., Szabo, Z., Fejes, Z., Ivády, G., Kerekes, G., Fagyas, M., Nagy, A. C., Szentkereszty, Z., Kappelmayer, J., Nagy, B. J.: Elevated level of serum human epididymis protein 4 (HE4) predicts disease severity and mortality in COVID-19 pneumonia.
BMC Pulm Med. 23 (1), 1-11, 2023.
Journal metrics:
Q2 Pulmonary and Respiratory Medicine
14.
Csoma, E., Nagy, K. Á., Sütő, R., Szakács, S. E., Pócsi, M., Nagy, A. C., Bíró, K., Kappelmayer, J., Nagy, B. J.: Evaluation of the diagnostic performance of two automated SARS-CoV-2 neutralization immunoassays following two doses of mRNA, adenoviral vector, and inactivated whole-virus vaccinations in COVID-19 naïve subjects.
Microorganisms. 11 (5), 1-13, (article identifier: 1187), 2023.
Journal metrics:
Q2 Virology
Q2 Microbiology
Q2 Microbiology (medical)
15.
Rákóczi, É., Magócs, G., Kovács, S., Nagy, B. J., Szűcs, G., Szekanecz, Z.: Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccine Combined with BNT62b2 mRNA Booster Vaccine.
Diagnostics. 13 (3), 1-12, (article identifier: 556), 2023.
Journal metrics:
Q2 Clinical Biochemistry
16.
Pócsi, M., Fejes, Z., Bene, Z., Nagy, A. C., Balogh, I., Amaral, M. D., Macek, J. M., Nagy, B. J.: Human epididymis protein 4 (HE4) plasma concentration inversely correlates with the improvement of cystic fibrosis lung disease in p.Phe508del-CFTR homozygous cases treated with the CFTR modulator lumacaftor/ivacaftor combination.
J. Cyst. Fibros. 22 (6), 1085-1092, 2023.
Journal metrics:
D1 Pediatrics, Perinatology and Child Health
D1 Pulmonary and Respiratory Medicine
17.
Csiki, D. M., Ababneh, H. M., Tóth, A., Lente, G., Szöőr, Á., Tóth, A., Fillér, C., Juhász, T., Nagy, B. J., Balogh, E., Jeney, V.: Hypoxia-inducible factor activation promotes osteogenic transition of valve interstitial cells and accelerates aortic valve calcification in a mice model of chronic kidney disease.
Front. Cardiovasc. Med. 10, 1-15, (article identifier: 1168339), 2023.
Journal metrics:
Q2 Cardiology and Cardiovascular Medicine
18.
Szuromi, L., Hajas, O., Nagy-Baló, E., Forgács, I. N., Nagy, L. T., Fagyas, M., Tóth, A., Nagy, B. J., Kappelmayer, J., Csanádi, Z.: Long-Term Changes in the Biomarkers of Left Atrial Fibrosis after Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation.
Rev. Cardiovasc. Med. 24 (6), 171, (article identifier: 171), 2023.
Journal metrics:
Q2 Cardiology and Cardiovascular Medicine
Q3 Medicine (miscellaneous)
19.
Király, J., Szabó, E., Fodor, P., Fejes, Z., Nagy, B. J., Juhász, É., Vass, A., Choudhury, M., Kónya, G., Halmos, G., Szabó, Z.: Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways.
Molecules. 28 (18), 1-22, (article identifier: 6725), 2023.
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
20.
Illési, Á., Fejes, Z., Pócsi, M., Bekéné Debreceni, I., Hódosi, K., Nagy, B. J., Kappelmayer, J., Kőszegi, Z., Csanádi, Z., Szűk, T.: Technically Challenging Percutaneous Interventions of Chronic Total Occlusions Are Associated with Enhanced Platelet Activation.
J Clin Med. 12 (21), 1-14, (article identifier: 6829), 2023.
Journal metrics:
Q1 Medicine (miscellaneous)
2022
21.
Nagy, B. J., Csoma, E., Kappelmayer, J.: A SARS-COV-2 szerológiai tesztjei: a humorális immunválasz vizsgálata különféle laboratóriumi módszerekkel.
Metabolizmus. 20 (5), 254-262, 2022.
22.
Fagyas, M., Fejes, Z., Sütő, R., Nagy, Z., Székely, B., Pócsi, M., Ivády, G., Bíró, E., Bekő, G., Nagy, A. C., Kerekes, G., Szentkereszty, Z., Papp, Z., Tóth, A., Kappelmayer, J., Nagy, B. J.: Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients.
Int. J. Infect. Dis. 115, 8-16, 2022.
Journal metrics:
D1 Infectious Diseases
D1 Medicine (miscellaneous)
Q1 Microbiology (medical)
23.
Müller, J., Szűcs-Farkas, D., Szegedi, I., Csóka, M., Garami, M., Tiszlavicz, L. G., Hauser, P., Kriván, G., Csanádi, K., Ottóffy, G., Nagy, B. J., Kiss, C., Kovács, G.: Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary.
Pathol. Oncol. Res. 28, 1-6, (article identifier: 1610261), 2022.
Journal metrics:
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Oncology
Q2 Pathology and Forensic Medicine
24.
Husi, K., Pinczés, L. I., Fejes, Z., Nagy, B. J., Illés, Á., Miltényi, Z.: Combined prognostic role of TARC and interim 18F-FDG PET/CT in patients with Hodgkin lymphoma-real world observational study.
Hell. J. Nucl. Med. 25 (2), 125-131, 2022.
Journal metrics:
Q3 Medicine (miscellaneous)
Q3 Radiology, Nuclear Medicine and Imaging
25.
Tóth, A., Csiki, D. M., Nagy, B. J., Balogh, E., Lente, G., Ababneh, H. M., Szöőr, Á., Jeney, V.: Daprodustat Accelerates High Phosphate-Induced Calcification Through the Activation of HIF-1 Signaling.
Front. Pharmacol. 13, 1-12, (article identifier: 798053), 2022.
Journal metrics:
Q1 Pharmacology
Q1 Pharmacology (medical)
DEENK University of Debrecen
© 2012 University of Debrecen